New Xpert MTB/XDR: added value and future in the field

Arnold Bainomugisa, Christopher Gilpin, Christopher Coulter, Ben J. Marais

Source: Eur Respir J, 56 (5) 2003616; 10.1183/13993003.03616-2020
Journal Issue: November
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Arnold Bainomugisa, Christopher Gilpin, Christopher Coulter, Ben J. Marais. New Xpert MTB/XDR: added value and future in the field. Eur Respir J, 56 (5) 2003616; 10.1183/13993003.03616-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
Source: Eur Respir J 2013; 42: 252-271
Year: 2013

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?
Source: Eur Respir J 2016; 48: 516-525
Year: 2016

Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?
Source: Eur Respir J 2012; 40: 161-168
Year: 2012

Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test
Source: Eur Respir J 2001; 18: Suppl. 33, 360s
Year: 2001

Clinical utility of the Xpert MTB/RIF test in induced sputum
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015

How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries?
Source: Eur Respir J 2015; 45: 549-554
Year: 2015

Diagnostic yield of AFB smear, culture, LiPA, GeneXpert: A clinician’s perspective
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015

Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Source: Eur Respir J 2012; 40: 442-447
Year: 2012

The new horizons of molecular diagnosis: do we still need conventional microbiology?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012

The yield of bronchoscopy in sputum Xpert MTB/Rif negative tuberculosis in the Xpert era.
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020

New-entrant screening for tuberculosis at port of entry in the U.K.: Is it time to change policy?
Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features
Year: 2012

Clinical utility of a lateral flow serologic test in the rapid diagnosis of pulmonary TB in a public-private mix for DOTS setting in Iloilo City, Philippines
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011

Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe
Source: Eur Respir J, 51 (5) 1800346; 10.1183/13993003.00346-2018
Year: 2018

Introduction: CPET in clinical practice. Recent advances, current challenges and future directions
Source: Eur Respir Monogr 2018; 80: x-xxv
Year: 2018

Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding
Source: Eur Respir J, 58 (6) 2100257; 10.1183/13993003.00257-2021
Year: 2021

A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019

Laboratory investigations of infection in COPD: current best practice and future possibilities
Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Year: 2008

Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016